Cargando…
Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report
Intravenous amiodarone treatment may cause hepatic toxicity. N-acetylcysteine (NAC) is a powerful antioxidant, reduces the level of free radicals by increasing glutathione levels, and is used in acetaminophen intoxication. An 83-year-old female Caucasian patient who had congestive heart failure and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216127/ https://www.ncbi.nlm.nih.gov/pubmed/33976000 http://dx.doi.org/10.4103/ijp.IJP_683_20 |
_version_ | 1783710360667160576 |
---|---|
author | Alanli, Recep Kucukay, Murat Bulent Ozdemir, Ozcan |
author_facet | Alanli, Recep Kucukay, Murat Bulent Ozdemir, Ozcan |
author_sort | Alanli, Recep |
collection | PubMed |
description | Intravenous amiodarone treatment may cause hepatic toxicity. N-acetylcysteine (NAC) is a powerful antioxidant, reduces the level of free radicals by increasing glutathione levels, and is used in acetaminophen intoxication. An 83-year-old female Caucasian patient who had congestive heart failure and implantable cardioverter-defibrillator was admitted to the hospital with palpitations and confusion. After analysis of ICD device, ventricular tachycardia, ventricular fibrillation runs of patient and intervention of ICD device with electric shocks were noticed. Intravenous 1200 mg amiodarone infusion was administered as treatment. Later, her transaminase levels increased dramatically. Hepatic injury due to intravenous administration of amiodarone was diagnosed and 1200 mg/day intravenous NAC was given. After 72 h of NAC treatment, hepatic enzymes were found to be recovering. After parenteral amiodarone administration, patients must be monitored for acute hepatotoxicity. This article accentuates the benefits of NAC treatment in drug-induced liver injury. |
format | Online Article Text |
id | pubmed-8216127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-82161272021-07-02 Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report Alanli, Recep Kucukay, Murat Bulent Ozdemir, Ozcan Indian J Pharmacol Drug Watch Intravenous amiodarone treatment may cause hepatic toxicity. N-acetylcysteine (NAC) is a powerful antioxidant, reduces the level of free radicals by increasing glutathione levels, and is used in acetaminophen intoxication. An 83-year-old female Caucasian patient who had congestive heart failure and implantable cardioverter-defibrillator was admitted to the hospital with palpitations and confusion. After analysis of ICD device, ventricular tachycardia, ventricular fibrillation runs of patient and intervention of ICD device with electric shocks were noticed. Intravenous 1200 mg amiodarone infusion was administered as treatment. Later, her transaminase levels increased dramatically. Hepatic injury due to intravenous administration of amiodarone was diagnosed and 1200 mg/day intravenous NAC was given. After 72 h of NAC treatment, hepatic enzymes were found to be recovering. After parenteral amiodarone administration, patients must be monitored for acute hepatotoxicity. This article accentuates the benefits of NAC treatment in drug-induced liver injury. Wolters Kluwer - Medknow 2021 2021-04-28 /pmc/articles/PMC8216127/ /pubmed/33976000 http://dx.doi.org/10.4103/ijp.IJP_683_20 Text en Copyright: © 2021 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Drug Watch Alanli, Recep Kucukay, Murat Bulent Ozdemir, Ozcan Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report |
title | Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report |
title_full | Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report |
title_fullStr | Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report |
title_full_unstemmed | Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report |
title_short | Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report |
title_sort | successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: a case report |
topic | Drug Watch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216127/ https://www.ncbi.nlm.nih.gov/pubmed/33976000 http://dx.doi.org/10.4103/ijp.IJP_683_20 |
work_keys_str_mv | AT alanlirecep successfultreatmentofamiodaroneinducedhepaticinjurywithnacetylcysteineacasereport AT kucukaymuratbulent successfultreatmentofamiodaroneinducedhepaticinjurywithnacetylcysteineacasereport AT ozdemirozcan successfultreatmentofamiodaroneinducedhepaticinjurywithnacetylcysteineacasereport |